Full View

Betrixaban: a new oral factor Xa inhibitor for extended venous thromboembolism prophylaxis in high-risk hospitalized patients

SG Garland, CE DeRemer… - Annals of …, 2018 - journals.sagepub.com
Objective: To review the pharmacology, pharmacokinetics, efficacy, and safety of the factor
Xa (FXa) inhibitor betrixaban for extended-duration prophylaxis of acute medically ill …
被引用次数：13 相关文章

Betrixaban: A New Oral Factor Xa Inhibitor for Extended Venous Thromboembolism Prophylaxis in High-Risk Hospitalized Patients

SG Garland, CE DeRemer… - The Annals of …, 2018 - pubmed.ncbi.nlm.nih.gov
Objective To review the pharmacology, pharmacokinetics, efficacy, and safety of the factor
Xa (FXa) inhibitor betrixaban for extended-duration prophylaxis of acute medically ill …

Betrixaban: A New Oral Factor Xa Inhibitor for Extended Venous Thromboembolism Prophylaxis in High-Risk Hospitalized Patients.

SG Garland, CE DeRemer, SM Smith… - The Annals of …, 2018 - europepmc.org
OBJECTIVE: To review the pharmacology, pharmacokinetics, efficacy, and safety of the
factor Xa (FXa) inhibitor betrixaban for extended-duration prophylaxis of acute medically ill …

[引用][C] Betrixaban: A New Oral Factor Xa Inhibitor for Extended Venous Thromboembolism Prophylaxis in High-Risk Hospitalized Patients

SG Garland, CE DeRemer, SM Smith… - Annals of …, 2018 - elibrary.ru